Details for 2016190004
Up to date per 01.04.2026
Actions
Details for 2016190004
Granted/Registered
European Patent
14.06.2017 A
20.04.2022 B1
15.07.2009
US
225805 P
12.01.2010
US
294426 P
A61K 39/155 20060101AFI20170724BHEP
Owner
GlaxoSmithKline Biologicals S.A.Rue de l'Institut, 89 1330 RixensartBE
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
SWANSON, Kurtc/o Novartis Vaccines and Diagnostics, Inc. IP Services M/S X-100B P.O. Box 8097 Emeryville, CA 94662-8097US
DORMITZER, Philip, R.c/o Novartis Vaccines and Diagnostics, Inc. IP Services M/S X-100B P.O. Box 8097 Emeryville, CA 94662-8097US
Information about Fees